Skip to search formSkip to main contentSkip to account menu

Etretinate

Known as: Ethyl-all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate, Ethyl Etrinoate, 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester, (all-E)- 
A synthetic oral retinoid that is a prodrug of acitretin. Etretinate activates retinoid receptors, causing an induction of cell differentiation… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1992
Highly Cited
1992
SIR. We wish to report a case of hidradenitis suppurativa and retroauricular acne successfully treated with low dose etretinate… 
Highly Cited
1991
Highly Cited
1991
Abstract 
Highly Cited
1987
Highly Cited
1987
Following recent reports of the development of skeletal abnormalities in patients treated with etretinate (Tigason®), we have… 
1984
1984
Seventeen patients with palmoplantar pustular psoriasis and three with hyperkeratotic psoriasis of palms and soles were treated… 
1984
1984
A 19‐year‐old patient with lamellar ichthyosis is described. She received etretinate during 5 consecutive years. A serious… 
Highly Cited
1983
Highly Cited
1983
Twelve patients with various types of lymphoma were treated with etretinate. The diagnosis included parapsoriasis en plaque… 
Highly Cited
1982
Highly Cited
1982
A double‐blind study of twenty‐eight patients with severe oral lichen planus treated with etretinate (75 mg daily) or a placebo…